PLANTS, THEIR PROPERTIES, YOUR BALANCE.

TRANSPARENCY & METHOD

Knowledge can be checked.

A compelling story is not enough. Information in the herbarium should be traceable, understandable and open to discussion.

Our editorial method

Each profile starts with a specific botanical species and plant part. Depending on the available evidence, it draws on EMA or WHO monographs, ANSM and ANSES information, botanical references and scientific publications. References and the date they were consulted appear at the end of each profile.

This herbarium is a documentary synthesis. Some profiles concern distinct species covered by a shared monograph; this scope is made explicit. Profiles marked “Limited evidence” do not recommend therapeutic use and are excluded from searches by need. This synthesis has not undergone clinical validation or independent medical review. References may change; consult the original documents and your product leaflet.

An inventory is not a recommendation

Inclusion in a French Pharmacopoeia list documents a species and plant part; it does not prove clinical efficacy or provide a recipe. ANSM list B covers plants whose potential adverse effects outweigh the expected therapeutic benefit. These profiles are documentary, highlight the risks and do not recommend home use.

Botanical synonyms are compared to avoid duplicates. Some plants have several scientific names; each profile explains the name used and any limitations. Insufficiently verified profiles remain drafts, accessible only in the administration area.

Understanding the evidence categories

Traditional: a long-standing use considered plausible in the monograph; this is not a demonstration of clinical effectiveness.

Clinical: results in humans for a specific preparation and context; they do not automatically apply to all preparations.

Well-established medicinal use (EMA): a recognised status for specific preparations and indications. This category is distinguished from human studies directly conducted with the species presented; some assessments rely on indirect evidence, as explained in the profile.

Preclinical: laboratory or animal observations, which alone do not demonstrate a benefit in humans.

Insufficient evidence: the references consulted do not establish a therapeutic benefit. This demonstrates neither effectiveness nor safety.

How to read the research

The profiles explain constituents, proposed mechanisms and the research actually consulted. Each result is accompanied by the research type, preparation and limitations. A human study may be negative or contradictory; the label “Human studies” alone does not mean that a plant is effective.

When several species appear in the same monograph, shared findings are identified. A trial involving a mixture or a particular extract does not automatically establish the action of a plant alone or of all its preparations.

Preparations are not interchangeable

The plant part, solvent, concentration and route of use all matter. An indication for an extract does not establish the same effect for a herbal tea or essential oil.

Herbarium references

1503 references

  1. EMA — Matricaria recutita L.: summary and documentsAccessed on 08/10/2026
  2. EMA — monograph on Matricaria recutita L.Accessed on 08/10/2026
  3. Royal Botanic Gardens, Kew — botanical identityAccessed on 08/10/2026
  4. EMA — Assessment report on Matricaria recutita L., flos and Matricaria recutita L., aetheroleumAccessed on 09/10/2026
  5. NCCIH — Chamomile: Usefulness and SafetyAccessed on 09/10/2026
  6. Mao et al. (2016) — Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trialAccessed on 09/10/2026
  7. EMA — Glossary on herbal teas: general preparation method, §4Accessed on 09/10/2026
  8. EMA — Chamaemelum nobile (L.) All.: overview and documentsAccessed on 08/10/2026
  9. EMA — monograph on Chamaemelum nobile (L.) All.Accessed on 08/10/2026
  10. Royal Botanic Gardens, Kew — botanical identityAccessed on 08/10/2026
  11. EMA — Assessment report on Chamaemelum nobile (L.) All., flosAccessed on 09/10/2026
  12. Sándor et al. (2018) — Evidence Supports Tradition: The in Vitro Effects of Roman Chamomile on Smooth MusclesAccessed on 09/10/2026
  13. Wilkinson et al. (1999) — An evaluation of aromatherapy massage in palliative careAccessed on 09/10/2026
  14. EMA — Mentha × piperita L.: summary and documentsAccessed on 08/10/2026
  15. EMA — monograph on Mentha × piperita L.Accessed on 08/10/2026
  16. Royal Botanic Gardens, Kew — botanical identityAccessed on 08/10/2026
  17. EMA — Assessment report on Mentha x piperita L., folium and aetheroleum, Revision 1Accessed on 09/10/2026
  18. Weerts et al. (2020) — Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel SyndromeAccessed on 09/10/2026
  19. Nee et al. (2021) — Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled TrialAccessed on 09/10/2026
  20. EMA — Melissa officinalis L.: summary and documentsAccessed on 08/10/2026
  21. EMA — monograph on Melissa officinalis L.Accessed on 08/10/2026
  22. Royal Botanic Gardens, Kew — botanical identityAccessed on 08/10/2026
  23. EMA — Assessment report on Melissa officinalis L., foliumAccessed on 09/10/2026
  24. Awad et al. (2009) — Bioassay-guided fractionation of lemon balm (Melissa officinalis L.) using an in vitro measure of GABA transaminase activityAccessed on 09/10/2026
  25. Kennedy et al. (2004) — Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm)Accessed on 09/10/2026
  26. EMA — Thymus vulgaris L.: summary and documentsAccessed on 08/10/2026
  27. EMA — monograph on Thymus vulgaris L.Accessed on 08/10/2026
  28. Royal Botanic Gardens, Kew — botanical identityAccessed on 08/10/2026
  29. EMA — Assessment report on Thymus vulgaris L., Thymus zygis L., herbaAccessed on 09/10/2026
  30. Kemmerich et al. (2006) — Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled clinical trialAccessed on 09/10/2026

Illustration credits

The profiles combine historical botanical plates and identified photographs. Credits and licences appear in each illustrated profile, with a link to the original. A profile may be published without an image when the visual identification is not sufficiently certain. The midnight-blue composition is a generated atmospheric image; it is not a botanical identification aid.

Something to correct?

A species error, a reference to update or a useful clarification: share your comments with Myriam through the contact form.

Suggest a correction
WhatsApp Appointments